These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19474172)

  • 1. 5-HT2C-like receptors in the brain of Xenopus laevis initiate sex-typical fictive vocalizations.
    Yu HJ; Yamaguchi A
    J Neurophysiol; 2009 Aug; 102(2):752-65. PubMed ID: 19474172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous serotonin acts on 5-HT2C-like receptors in key vocal areas of the brain stem to initiate vocalizations in Xenopus laevis.
    Yu HJ; Yamaguchi A
    J Neurophysiol; 2010 Feb; 103(2):648-58. PubMed ID: 19955293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhythm generation, coordination, and initiation in the vocal pathways of male African clawed frogs.
    Yamaguchi A; Cavin Barnes J; Appleby T
    J Neurophysiol; 2017 Jan; 117(1):178-194. PubMed ID: 27760822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
    Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity.
    Booth RG; Fang L; Huang Y; Wilczynski A; Sivendran S
    Eur J Pharmacol; 2009 Aug; 615(1-3):1-9. PubMed ID: 19397907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenopus vocalizations are controlled by a sexually differentiated hindbrain central pattern generator.
    Rhodes HJ; Yu HJ; Yamaguchi A
    J Neurosci; 2007 Feb; 27(6):1485-97. PubMed ID: 17287524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
    Canal CE; Morgan D; Felsing D; Kondabolu K; Rowland NE; Robertson KL; Sakhuja R; Booth RG
    J Pharmacol Exp Ther; 2014 May; 349(2):310-8. PubMed ID: 24563531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice.
    Halberstadt AL; van der Heijden I; Ruderman MA; Risbrough VB; Gingrich JA; Geyer MA; Powell SB
    Neuropsychopharmacology; 2009 Jul; 34(8):1958-67. PubMed ID: 19322172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motoneuron excitability and muscle spasms are regulated by 5-HT2B and 5-HT2C receptor activity.
    Murray KC; Stephens MJ; Ballou EW; Heckman CJ; Bennett DJ
    J Neurophysiol; 2011 Feb; 105(2):731-48. PubMed ID: 20980537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.
    Dekeyne A; Mannoury la Cour C; Gobert A; Brocco M; Lejeune F; Serres F; Sharp T; Daszuta A; Soumier A; Papp M; Rivet JM; Flik G; Cremers TI; Muller O; Lavielle G; Millan MJ
    Psychopharmacology (Berl); 2008 Sep; 199(4):549-68. PubMed ID: 18523738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDAR-dependent control of call duration in Xenopus laevis.
    Zornik E; Katzen AW; Rhodes HJ; Yamaguchi A
    J Neurophysiol; 2010 Jun; 103(6):3501-15. PubMed ID: 20393064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes.
    Villalobos CA; Bull P; Sáez P; Cassels BK; Huidobro-Toro JP
    Br J Pharmacol; 2004 Apr; 141(7):1167-74. PubMed ID: 15006903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
    Zaniewska M; McCreary AC; Wydra K; Filip M
    Synapse; 2010 Jul; 64(7):511-9. PubMed ID: 20196140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two conserved vocal central pattern generators broadly tuned for fast and slow rates generate species-specific vocalizations in
    Yamaguchi A; Peltier M
    Elife; 2023 May; 12():. PubMed ID: 37184077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Involvement of some subtypes of 5-HT2-receptors in affective behavior in female rats].
    Fedotova IuO; Ordian NE; Frolova HO; Soboliev VI
    Fiziol Zh (1994); 2012; 58(6):75-80. PubMed ID: 23530416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical spinal 5-HT
    Tadjalli A; Mitchell GS
    J Appl Physiol (1985); 2019 Aug; 127(2):432-443. PubMed ID: 31219768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.
    Nelson DL; Lucaites VL; Wainscott DB; Glennon RA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):1-6. PubMed ID: 9933142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTS and rational drug design to generate a class of 5-HT(2C)-selective ligands for possible use in schizophrenia.
    Kozikowski AP; Cho SJ; Jensen NH; Allen JA; Svennebring AM; Roth BL
    ChemMedChem; 2010 Aug; 5(8):1221-5. PubMed ID: 20533502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.